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Abstract
Burkholderia pseudomallei, as a saprophytic bacterium that can cause a severe sepsis disease named melioidosis, has
preserved several extra genes in its genome for survival. The sequenced genome of the organism showed high diversity
contributed mainly from genomic islands (GIs). Comparative genome hybridization (CGH) of 3 clinical and 2 environmental
isolates, using whole genome microarrays based on B. pseudomallei K96243 genes, revealed a difference in the presence of
genomic islands between clinical and environmental isolates. The largest GI, GI8, of B. pseudomallei was observed as a 2 sub-
GI named GIs8.1 and 8.2 with distinguishable %GC content and unequal presence in the genome. GIs8.1, 8.2 and 15 were
found to be more common in clinical isolates. A new GI, GI16c, was detected on chromosome 2. Presences of GIs8.1, 8.2, 15
and 16c were evaluated in 70 environmental and 64 clinical isolates using PCR assays. A combination of GIs8.1 and 16c
(positivity of either GI) was detected in 70% of clinical isolates and 11.4% of environmental isolates (P,0.001). Using BALB/c
mice model, no significant difference of time to mortality was observed between K96243 isolate and three isolates without
GIs under evaluation (P.0.05). Some virulence genes located in the absent GIs and the difference of GIs seems to contribute
less to bacterial virulence. The PCR detection of 2 GIs could be used as a cost effective and rapid tool to detect potentially
virulent isolates that were contaminated in soil.
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Introduction
B. pseudomallei is a Gram-negative bacillus that causes
melioidosis. It can be found as an environmental saprophyte in
soil or stagnant water in the endemic areas of Southeast Asia and
northern Australia [1]. Soil therefore is an important reservoir of
the organism. The depth of soils between 15 and 30 cm, with at
least 10% of moisture and pH 5–6 were reported to be related to
the presence of the organism in soil in northeast Thailand [2]. B.
pseudomallei is recognized as a Category B agent of bioterrorism
by the Centers for Disease Control and Prevention, USA (CDC)
[3]. It accounts for 20% of community-acquired septicemias in
the northeast of Thailand [4]. N.J. White reported that severe
melioidosis cases in Thailand resulted in approximately 50%
mortality [5]. Melioidosis presents as a variety of clinical
manifestations ranging from acute, sub-acute, chronic, or sub-
clinical with the commonest presentation as pneumonia [4].
Three main routes of B. pseudomallei infection are ingestion,
inhalation and inoculation. Although inhalation is reportedly
a common infection route, the actual contribution of each route
is unclear [6]. Currently, there is no effective vaccine for
melioidosis, and relapse is common and is at an unacceptable
rate [6]. Molecular typing methods revealed a large diversity
among B. pseudomallei isolates, from both environmental and
clinical specimens with significant differences in the classification
indices between these two sources [7,8] but isolates from each
source can be classified into the same molecular type [6].
Moreover, the clinical and environmental isolates showed no
difference in virulence as observed in a mouse model [9]. The
genotypes of isolates from each source, however, were not
investigated in the study. Nevertheless, the identification of the
potentially virulent organism in soil is still important to be used
in the control and tracking during an outbreak. Accessory genes
from genome analysis organize B. pseudomallei into three broad
clusters of clinical, environmental and animal groups but overlap
is still observed [10,11]. At present, there is no specific typing
method to distinguish the organism in soil as to whether it is
saprophytic or a potentially virulent organism.
B. pseudomallei K96243 was the first strain whose genome was
sequenced and analyzed [12]. As of now, there are several
genome sequences of B. pseudomallei from various countries
submitted to GenBank. Comparative genomic data indicated
a high complexity of the genome obtained through horizontal
gene acquisition that is an important feature of recent genetic
evolution and that has resulted in a genetically diverse
pathogenic species [10,13]. The composition of bacterial
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a variety of processes including horizontal gene transfer (HGT)
which incorporates genetic elements from another organism
directly into the genome resulting in genomic islands [14]. These
sequences can permanently alter bacterial genotypes and result in
adaptation to their environment by genome optimization [11].
The term genomic island was introduced to describe regions that
contained a diverse range of functions, such as (i) the ability to
utilize novel carbon and nitrogen sources (metabolic islands); (ii)
the ability to break down novel compounds (degradation islands);
(iii) resistance to antibiotic and heavy metals (resistance islands);
and (iv) the ability to cause disease (pathogenic islands) [14,15].
Some pathogens may therefore cause disease by using virulence
factors obtained through HGT [16]. Thus, the genomic islands
may play an important role in the development of new species,
subspecies, and also development of pathotypes [17]. Sixteen GIs
were first identified in the B. pseudomallei K96243 genome by
Holden, et al. [12] and several distinct GIs were depicted from
comparative genomes of 5 B. pseudomallei strains [13]. GIs 7 and
14 were found to be a part of the bacterial core genome and
others may variably contribute at least, in part, to pathogenesis
and adaptation to external environments [10]. Analysis of 5 GIs,
GI 2, 6, 9, 11 and 16, as representative of various functions in
each GI showed high diversity among clinical and environmental
isolates and showed no difference between these two sources
[18]. Several GIs in B. pseudomallei contain metabolic or
virulence-related genes that contribute to fitness of the organism
and may be selectively present in clinical isolates. These GIs in
particular could then be used as a marker to identify potentially
virulent organisms in soil used for agriculture or in other
environments in the endemic areas.
The whole genome DNA microarray has been used as a tool
for genomic comparisons to determine presence or absence of
genes in a single hybridization experiment [11]. These arrays
provide a powerful method to investigate the plasticity of the
genome that may reflect the future bacterial capabilities within
a short time. For example, DNA microarrays have been used to
investigate genetic contents of closely related species such as
Brucella spp. [19], Streptomyces coelicolor A3 (2) [20], and absence or
divergence of Streptomyces coelicolor M145 genes in S. lividans TK21
[21] or genome plasticity in Mycobacterium avium subspecies [22].
The DNA microarray is employed to study the contribution of L-
arabinose metabolism to the virulence of B. pseudomallei [23].
Comparative genomic hybridization analysis also helps describing
the genome evolution through genes lost among B. pseudomallei, B.
mallei and B. thailandensis [24,25].
In this study, the whole genome DNA microarray (Burkholderia
mallei/pseudomallei microarray) version 2 from the Pathogen
Functional Genomics Resource Center was used. The 9,826
oligos, representing all 5,854 ORFs of B. pseudomallei K96243, are
designed based on ORF sequences across the genomes of
Burkholderia mallei ATCC 2344, B. pseudomallei K96243 and B.
pseudomallei 1710b to cover as many ORFs of all strains as possible,
without unnecessary duplication. The genetic DNA of 2 environ-
mental and 3 clinical isolates were compared with that of B.
pseudomallei K96243 on the DNA microarray slides to identify
regions of genomes that could be used to distinguish clinical from
environmental isolates. PCR was subsequently used to confirm the
presence of selected regions that distinguish the source of the
organism in 70 soil and 64 clinical isolates.
Results
Microarray comparison of genomic DNA from five B.
pseudomallei clinical and environmental isolates with B.
pseudomallei K96243 strain
This microarray comparison only allows the detection of regions
that are missing in other B. pseudomallei isolates relative to the
K96243 genome, but could not detect the presence of unique
regions of the other isolates. Hybridization results revealed the
presence of the majority of K96243 ORFs across the five genomes,
as indicated by similar ORFs with signal intensity levels from the
microarray comparison (i.e. log2 ratios are close to zero; Figure 1).
Genes with log2 hybridization ratios of at least minus two standard
deviations less than the overall mean were considered potentially
absent or divergent in the tested isolates. These absent genes when
clustered and consisting of at least six consecutive genes were
designated as a genomic island (GI). The comparative results
between environmental (Figure 1A, BP45s) or clinical isolates
(Figure 1B, H307) with K96243 are shown as the log2 ratio for
each gene position. There were 15 GIs (peaks) detected as absent
in five B. pseudomallei isolates when compared with the K96243
(Table 1), of which most corresponded to the K96243 GIs (GI2, 3,
4, 5, 6, 8, 10, 11, 12, 13, 15 and 16) reported by Holden et al. [12]
and the GI16b as reported by Tuanyok et al. [13]. The largest GI,
GI8 (92.3 kb), in the K96243 strain was seen as two separated
absent regions of 15.7 kb (CDS coordinates BPSL1638-
BPSL1656) and 21.8kb (CDS coordinates BPSL1693-1708A) with
distinguishable %GC contents (Table 1). They were assigned here
as GIs8.1 and 8.2 because they were located at the same reference
genomic location with GI8 in K96243 but contained different
gene contents. Since the methods used here compared gene
compositions with the K96243, it can only report regions present
in or absent from the K96243, but cannot identify the unique gene
composition in other isolates. Therefore, the GI nomenclature as
proposed by Tuanyok et al. [13] may not be properly applied.
There were four conserved GIs (GIs1, 7, 9 and 14) present in all 5
isolates, of which GIs7 and 9 were reported to be a part of the core
genome of B. pseudomallei strain [12].
Comparative genome hybridization in this study also detected
a new GI, named GI16c located downstream from GI16 on
chromosome 2, with the size of 8.3 kb determined by the
microarray. It consists of eight contiguous probes (CDS coordinates
BPSS2148-BPSS2154) containing common characteristics of a GI
such as a transposase gene and insertion element. It appeared to be
absent inall soil isolates and present in1/3 oftested clinical isolates.
Moreover, from the log2 hybridization ratios of genes from
each isolate to those of a clinical isolate of the reference K96243,
higher similarity (shorter peaks, closer to 0) was observed in each
GI in the clinical isolates than in the soil isolates (Figure 1). The
overall profiles from the comparison of environmental isolates (2
total) and clinical isolates (3 total) to the K96243 were also
different (Figure S1). When the presence or absence of each GI
in these 5 isolates was compared with K96243, clinical isolates
(H307, P54, P82) contained lower numbers of absent genomic
islands (10–11 absent GIs) than environmental isolates (BP45s
and BP28L). GIs 6, 12 and 16c in clinical isolates showed some
variability in the GI patterns. A total of eight regions (GIs2, 3, 4,
5, 11, 13, 16 and 16b) were absent in both tested clinical and soil
isolates. GIs 8.1, 8.2 and 15 were absent in the soil isolates but
present in all of the clinical isolates. Their functions are related
to metabolism, cellular process, biosynthesis and transport
proteins (Table 2).
The absence of the GIs3, 4, 6, 10, 13, 15 and 16c identified by
DNA microarray was selected for further confirmation by PCR
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control) and a gene inside each GI. The data correlated with the
microarray data (data not shown).
PCR detection of selected GIs to differentiate clinical and
environmental isolates
GIs 8.1, 8.2 and 15 found only in 3 clinical but not in 2 soil
isolates used in CGH and a new GI (GI16c) discovered here
were selected and validated by PCR in 70 environmental and 64
clinical isolates. The GI 13 absent in all 5 tested isolates was
included as a negative control. The percentage of positive
detections of GI8.1, 8.2, 15 and 16c was 60.9, 32.8, 9.4 and 50%
in clinical isolates and 10, 2.9, 5.7 and 4.3% in soil isolates
(Table 3). The presence of GI13, a negative control, was rarely
found in only 2% of all samples. These results support the
findings obtained from DNA microarray data. Moreover, when
these GIs were used to differentiate clinical isolates from soil
isolates by PCR detection, GI8.1, 8.2 and 16c but not GI15 gave
significantly different results (P,0.001). GIs8.1 and 16c were
commonly present in 39 clinical isolates and other 6 isolates were
positive for GI16c. Therefore, the PCR detection of GI8.1 and
16c in combination (positivity of either GI) as markers can detect
70% (45/64) of clinical isolates and 11.4% (8/70) of environ-
mental isolates (P,0.001) (Table 3).
Association between genomic islands and bacterial
virulence in mice
The virulence of BP45S (ribotype 23) with 15 GIs absent, P54
(ribotype 23) and P82 (ribotype 13) (Table 4) with 11 GIs absent
when compared with K96243 and the referenced K96243 strain
were evaluated in BALB/c mice with intraperitonealy injection
doses of 2610
6,1 610
5 and 5610
3 cfu. The highest dose gave less
than 30% survival of all groups within 3 days and the lowest dose
prolonged survival more than 90% in all groups for more than
30 days. Only 1610
5 cfu showed a difference in survival rates.
Repeated evaluation of survival rates in other independent
experiments with 1610
5 cfu injections, however, did not show
a significant difference of survival rates between clinical and
Figure 1. Comparative genome analyses of B. pseudomallei K96243 with B. pseudomallei from environmental and clinical isolates. The
comparison between K96243 and environmental isolate (BP45s) was shown in (A) and clinical isolate (H307) in (B). The log2 hybridization ratio of the
tested isolate over the K96243 was plotted on the Y axis and positions of genes on the X axis. Low values of the Log2 hybridization ratio, seen as
peaks, imply absence of genes designated as GIs. The slide averaging window of 6 genes, one gene per step, was applied to the normalized data and
smoothed out the fluctuations of the data. Each GI contains at least 6 CDS that have values less than 22SD.
doi:10.1371/journal.pone.0037762.g001
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K96243 (data not shown).
Discussion
Comparative genome hybridization of five tested isolates to
K96243 indicated their average core genome close to 86% as
reported by Sim et al. [10]. The microarray-based CGH
technology has been shown as a remarkable tool for the
identification and fine discrimination between close species, and
additionally provided insight into the adaptation to its ecological
niche as reported in L. taiwanensis BL263 [26]. The variability of
GIs among clinical isolates was higher than that of environmen-
tal isolates. The different overall comparison profiles between
clinical and environmental isolates, as shown in figure 1 and
figure S1 of the other 3 isolates can clearly distinguish the source
of isolation. Even though the transfer of GIs is assumed to be
spontaneous, stress responses may provide selective pressure
responsible for variation of GIs and gene insertion in each GI of
the clinical isolates may play an important role for host
adaptation. The absence or divergence of B. pseudomallei GIs
found by comparative genome hybridization using the K96243
sequenced strain as a reference was consistent with the recent
studies using bioinformatics tools or in silico analysis [12,13,18].
Moreover, two out of four GIs (GsI7 and 9) found to be common
among the 5 tested isolates are also reported as parts of the core
genome by Sim et al.[10]. Interestingly, the method was able to
identify a new GI of the genomic islands (GI 16c) on
chromosome 2, which was not previously reported [12,13]. A
small difference in %GC (69.5%) of GI16c when compared to
the rest of the B. pseudomallei genome (68%) and a lack of flanking
tRNA and 39 end repeat may make it difficult to be detected by
other genome sequence comparison methods. GI16c, however,
contains transpose and insertion element genes which are
involved in genome mobility and are common characteristics of
GIs. This GI may be in the stage of evolutionary regression that
eliminated some GI functions [27].
The GI 8, which is the largest GI of K96243, was identified in
this study to contain 2 absent regions with a distinguishable %GC.
The percentage of these 2 regions present in 64 clinical isolates was
also clearly different. This GI region was reported to contain
several types of gene contents that varied in size (15.8–92.3 kb)
[13]. The hyper-variation in this location supported the cause of
genome plasticity created by various GIs. The comparative
genome analysis of the B. pseudomallei genomes available in the
public domain [28] also indicated a common finding of variability
in the number of genes and gene shuffling within each GI obtained
through horizontal transfer from other organisms.
ThePCRdetectionforthepresenceoffiveGIs,GIs2,6,9,11and
16, with various functions, among 186 environmental and clinical
isolates was reported to be no different [18]. Two environmental
isolates in this study were carefully picked from an undisturbed soil
location in Nampong district, Khon Kaen province as soil
representativeisolates.Whentheywereusedtogetherwith3clinical
isolates in comparative genome hybridization, 3 GIs (GIs8.1, 8.2
and 15) were clinically specific GIs as they were only identified in
clinical but not soil isolates. Their functions are related to
metabolism and transport proteins that may support the survival
of the organism inside their host. The PCR detection of these GIs
indicated their low presentation in soil isolates (3–10%) but varied
among clinical isolates. Interestingly, the new GI16c was rarely
detected in soil samples but was present in up to 50% in clinical
isolates. GIs8.1, 8.2 and 16c can significantly distinguish clinical
from soil isolates. The PCR detection using a combination of
primers specific toGIs8.1 and 16c waspositive upto 70%of clinical
isolates. The access of B. pseudomallei genomes through the VISTA
component of Integrated Microbial Genomes (IMG) [29] was done
to investigate the presence of these 2 GIs (GIs8.1 and 16c) in 22
publicallyavailablegenomesequences,ofwhich4arecompleteand
18 are drafts [30]. Twenty-one of them are clinical isolates from
several countries including Thailand and 1 is an environmental
isolate(S13)fromSingapore.GIs8.1and16cwerepresentin57(12/
21) and 62 (13/21)% of clinical isolates and 71.4% by 2 GIs
detection. None of them were present in the S13 soil isolate [28]. A
combination of the 3 primer sets for GIs8.1, 8.2 and 16c aids the
percentage of clinical isolate detections in this study to 76.6%
(Table 3). Therefore, the development of multiplex PCR for GI8.1
and 16c detection or all these 3 GIs can be applied to detect
potentially virulent isolates in soil in endemic areas of northeast
Thailandinasingleprocess.AsGIsineachB.pseudomalleiisolateare
diverse and may be changed through adaptation and evolution,
further evaluation of this PCR detection with isolates from other
areas istherefore advised before it canbe applied to other regions of
the world.
In this study, it is clear that differences of time to mortality were
not observed in BALB/c mice model after inoculation with B.
pseudomallei clinical and environmental isolates with the same
ribotype (ribotype 23) and another clinical isolate of ribotype 13
[8] with a different absence of GIs. Clinically specific GIs encode
several genes with metabolic and transport functions that might be
important in generation and acquisition of nutrients. Examples of
thesegenesaretheABCtransportsystem,hydrolase,oxygenaseand
the Gnt-R family of regulatory proteins. The islands also include
genes encoded for the outer membrane porin protein and a surface
exposed protein such as BPSL1705, a Yad A- like protein (adhesion
Table 1. Summary of the genomic islands (GIs) identified to
be absent in tested isolates when compared with GIs in the
K96243.
GI
Coordinates of absent
region Size No. %GC
K96243 start CDS stop CDS (kb) CDSs
GI 2 BPSL0140 BPSL0176 27.3 37 65.7
GI 3 BPSL0549A BPSL0588 46.6 43 56.7
GI 4 BPSL0745 BPSL0770 36.5 26 56.4
GI 5 BPSL0939 BPSL0953 20.5 15 57.5
GI 6 BPSL1137 BPSL1157 14.6 22 58.9
GI 8.1* BPSL1638 BPSL1656 15.7 17 61.6
GI 8.2* BPSL1693 BPSL1708A 21.8 16 59.0
GI 10 BPSL3113 BPSL3118 7.1 6 54.6
GI 11 BPSL3257 BPSL3269 12.7 13 55.8
GI 12 BPSL3342 BPSL3349 9.5 8 56.8
GI 16b** BPSS0068 BPSS0080 16.7 13 59.4
GI 13 BPSS0378 BPSS0391A 18.4 18 59.0
GI 15 BPSS1047 BPSS1089 35.1 50 65.3
GI 16 BPSS2046 BPSS2076 50.4 34 60.8
GI 16c*** BPSS2148 BPSS2154 8.3 8 69.5
CDS=protein coding sequence.
*Absent region identified in GI8 of K96243 to contain 2 sub-GIs.
**A new GI discovered in B. pseudomallei genome (Tuanyok et al., 2008).
***A new GI detected by DNA microarray in this study.
doi:10.1371/journal.pone.0037762.t001
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virulence of B. pseudomallei through mediating host-cell interactions
andthereforewerepreviouslysuggestedtobeimportantinbacterial
survival or pathogenesis [12,31]. The BPSL1705 gene, however,
was confirmed by PCR amplification to be absent in all tested
isolates but was still present in the B. pseudomallei K96243 (data not
shown). Therefore, these genes might not play a direct role in the
virulenceofthisbacteriumaspreviouslysuggested,ortherearesome
other alternatives genes with similar functions to this gene in other
isolates. A similar story was also found for the cell surface protein or
hemagglutinin-related protein gene (BPSS2053) (in GI 16) that was
absentinalltestedisolatesbutpresentintheK96243.Thisgenewas
proposed to play a role in virulence by reducing the adherence to
human buccal epithelial cells [10]. Therefore, the difference in
severity of the disease should depend at least on a combination of
genes with more influence from host’s status as seen by the high risk
ofthisdiseaseindiabeticpeople.Nevertheless,thepossibilitythatthe
absent GI may be associated with acquisition of the bacteria that
were omitted by direct inoculation or the low sample size or even
simply that mice are different from humans has to be considered
Table 2. The GIs determined by DNA microarrays and their functional classification.
B. pseudomallei isolates
GIs Soil Clinical Function classification*
BP45s BP28L H307 P54 P82
2 222 2 2 Cellular processes, Regulatory, Cell envelope, DNA metabolism,
Transcription
3 222 2 2 Regulatory, Cell envelope, DNA metabolism, Protein fate, Energy
metabolism
4 222 2 2 Cellular processes/ Energy metabolism, Regulatory, DNA
metabolism
5 222 2 2 DNA metabolism, Transport and binding protein
6 222 ++Cell envelope, Energy metabolism/protein synthesis/regulatory
8.1 22++ + Energy metabolism, Regulatory, Central metabolism, Cell
envelope, Transport and binding protein
8.2 22++ + DNA metabolism, Regulatory, Cellular processes, Fatty acid
10 2 + 22 2 DNA metabolism, Regulatory
11 222 2 2 DNA metabolism
12 22+ 22Cellular protein, Protein fate
16b 222 2 2 Cell envelope, Regulatory, Transport and binding protein
13 222 2 2 DNA metabolism, Regulatory, Transcription
15 22++ + Cellular processes/biosynthesis, Regulatory, Cell envelope, DNA
metabolism, Transcription, Energy metabolism
16 222 2 2 Cellular process/protein fate, Energy metabolism/AA biosynthesis,
Regulatory, Central metabolism, Transcription, Transport and binding protein
16c 22+ 22Biosynthesis/transport, Transport protein
GIs present (+) and absent (2).
*Functional classification data obtained by Burkholderia pseudomallei K96243 genome annotation from Pathema Bioinformatics Resource Center [28].
doi:10.1371/journal.pone.0037762.t002
Table 3. PCR detection of four GIs in 70 soil and 64 clinical B. pseudomallei isolates.
GIs GI patterns % Positive by PCR P-value
Soil Clinical Soil Clinical
BP45s BP28L H307 P54 P82 (n=70) (n=64)
8.1 22++ + 10 60.9 ,0.001
8.2 22++ + 2.9 32.8 ,0.001
15 22++ + 5.7 9.4 0.518
16c 22+ 22 4.3 50 ,0.001
8.1+16c 22++ + 11.4 70.3 ,0.001
8.1+8.2+16c 22++ + 11.4 75 ,0.001
doi:10.1371/journal.pone.0037762.t003
Genomic Islands Detection of B. pseudomallei
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e37762before it can be concluded that the virulence of each isolate is not
different.
Besides examining the virulence genes located in some absent
GIs, PCR was used to investigate the presence of genes outside the
GIs that encode for other known virulence determinants such as
type III protein secretion systems (bsaQ), that are potential
virulence determinants such as surface polysaccharides
(BPSL2800), fimbriae and pili (BPSS0120) [12]. They were all
present in all 5 tested isolates. This may suggest that these other
virulence factors present in the B. pseudomallei genome are critical
to maintain its virulence. Similarly, regulatory genes known to
promote survival such as a sigma factor (rpoS) [32] were present in
all isolates. These factors in B. pseudomallei may contribute to the
fitness of the organism as well or even more than those obtained
recently from horizontal gene transfer.
In addition, the microarray data analysis of all isolates revealed
the presence of other virulence genes such as types I, II, III and
VI protein secretion systems [33], exoproteins and genes known
to promote survival in diverse and challenging environments
including secondary metabolite biosynthesis genes (siderophore,
malleobactin biosynthesis cluster, superoxide detoxification, Ser
proteases, phospholipase C, catalase, etc.) [12,34,35,36,37],
sigma factor [32,38], quorum sensing [39], reactive nitrogen
intermediates [40], O-antigen [41], chaperonin GroEL [42],
multidrug effect pump, secondary metabolism functions or drug
resistance functions, intracellular stress and motility and chemo-
taxis [12]. Therefore, these data confirm the previous report
from Ulett et al, 2001 that there is no difference in virulence
between clinical and environmental isolates. As their work does
not analyze the genotype of the compared isolates, this study
could then provide additional details to summarize that the
outcome of the infection mainly depends on the immune
response or susceptibility of the host rather than the genetic
background of the bacteria.
In conclusion, through whole genome comparative analysis by
DNA microarray hybridization, a new GI (GI16c) present on
chromosome 2 of B. pseudomallei was identified. The technique was
also able to show different hybridization profiles between clinical
and environmental isolates and identify 3 GIs that were found
more commonly in clinical isolates. The use of PCR to detect
GI8.1 and GI16c is a simple and cost effective method to screen
for potentially virulent isolates in the environment in endemic
areas, and it can further be applied for pathophysiological studies
of the bacteria.
Materials and Methods
Strains and culture conditions
B. pseudomallei K96243 sequenced strain was isolated from
a patient in Khon Kaen hospital, Thailand [12]. BP45s, BP28L
and the other 70 environmental isolates were isolated from
undisturbed soil in 3 districts of Khon Kaen province, northeast
Thailand (Table S1). H307, P54, P82 and the other 64 clinical
isolates were isolated from patients admitted to the Srinagarind
hospital, Khon Kaen province and other 16 provincial hospitals in
the northeast Thailand (Table S2). Details of the five isolates used
in CGH are summarized in Table 4. Ribotyping is a typing system
based on the diversity of ribosomal RNA gene of the organism [8]
and was applied to distinguish the ribotypes between environ-
mental and clinical isolates to be used in CGH. The bacteria were
identified by biochemical tests and confirmed by latex agglutina-
tion with a monoclonal antibody specific to B. pseudomallei [43].
The requirement for approval the use of all clinical isolates in
a study of this nature is exempt according to the human ethics
committee, Khon Kaen University.
To prepare a B. pseudomallei culture for mouse infection, 1% of
an overnight culture of each bacterium in trypticase soy broth
(TSB) was sub-cultured into TSB and incubated at 37
uC with
shaking until the OD600nm reached the mid-log phase. By using
the growth curve for each isolate, each bacterium was diluted with
phosphate buffered saline (pH 7.2) to the desired number of cells
that was later determined exactly by plate count.
Genomic DNA extraction and labeling
The overnight culture of B. pseudomallei in Luria Bertani broth
(LB broth) was used for genomic DNA extraction according to the
manufacturer’s protocol (Generation capture column, QIAGEN
Sciences, MD, USA). The 10–15 mg genomic DNA of B.
pseudomallei K96243 used as reference strain was labeled with
Cy3-dCTP whereas each B. pseudomallei isolate tested (BP45s,
BP28L, H307, P54, P82) was labeled with Cy5-dCTP fluorescent
dye using a standard nick-translation reaction to generate
randomly labeled DNA fragments according to the manufacturer’s
protocol (Promega, Madison, WI, USA). After the labeling
reaction was completed, unincorporated nucleotides were re-
moved by passage over a gel filtration spin column (Illustra
MicroSpin
TM G-50 Columns, GE Healthcare Bio-Sciences, NJ,
USA) according to the manufacturer’s recommendations.
DNA microarray
The whole genome DNA microarray slides of B. mallei and B.
pseudomallei version 2.0 were received from the PFGRC (Pathogen
Functional Genomics Research Center, MD, USA). The array
containsatotalof9,826oligoprobes(70-mer)representing multiple
strains and/or species (5,440 ORFs of B. mallei, 5,854 ORFs of B.
pseudomallei K96243 and 6,348 ORFs of B. pseudomallei 1710b). Each
probe was spotted in duplicate. Details of the Burkholderia mallei/
pseudomallei microarray were published through the Pathogen
Functional Genomics Research Center (PFGRC) [44].
Microarray hybridization and image analysis
The standard protocols established by the PFGRC for slide
preparation and hybridization were used [44]. Briefly, the array
slideswereimmersedintheprehybridizationsolution(5xSSC,0.1%
SDS,1%BSA)at42uCforatleastonehour.Theslideswerewashed
with MilliQ water until suds disappeared and washing was
continued twice more for 2 min each with MilliQ water on a rotary
shaker. The slides were then washed with isopropyl alcohol for
2 min before centrifuging at 1,0006g for 10 min at room
temperature.
For genomic DNA comparison, the DNA probes were prepared
by mixing 2 mg each of Cy5 labeled gDNA of the K96243 and
Cy3 labeled gDNA of a selected isolate and then drying in
a SpeedVac concentrator (SPD1010 SpeedVac System, Thermo
Savant, USA) for about 30 min. The probe was re-suspended in
Table 4. B. pseudomallei isolates used for DNA microarray.
Strain Host Sample origin Ribotype
BP45S Environment Soil 23
BP28L Environment Soil 13
H307 Male, 54 years Blood 23
P54 Female, 50 years Pus 23
P82 Male, 56 years Pus 13
doi:10.1371/journal.pone.0037762.t004
Genomic Islands Detection of B. pseudomallei
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e3776250 ml hybridization solution (50% formamide, 5x SSC, 0.1% SDS)
and hybridized onto the post-processed slides while the LifterSlip
Microarray Coverslips (Erie Scientific, USA) were placed over the
array slides and incubated at 42uC in a water bath for 16–20 h.
Each slide was then washed according to the standard protocols
recommended by PFGRC.
Microarray data analysis
The hybridized slides were scanned with a GenePix 4000B laser
scanner (Molecular Devices, Sunnyvale, CA, USA) and initially
analyzed with GenePix Pro 6.1 software. Briefly, signals below the
threshold level (the total pixel intensity of the spot is 65% lower
than the median background intensity at both wavelengths) or
‘‘empty’’ (ORF without oligo) and ‘‘bad’’ (flagged by visual
inspection of the spot images) spots were removed before
normalization. The data were normalized within each array by
the scaled print-tip (Lowess) method [45,46] and across arrays
using the Aroma package [47,48] available from Centre for
Mathematical Sciences, Lund, Sweden [49], using R project
environment [50]. The analysis for the presence or absence of GIs
was observed based on K96243 ORFs on the microarray. The low
values of Log2 hybridization ratios imply absence of genes
visualized by Treeview software was provided as figure S2. The
CDS coordinates of genes in 15 GIs were listed as table S3. The
microarray data have been deposited in NCBIs Gene Expression
Omnibus [51] and all data is MIAME compliant which are
accessible through GEO Series accession number GSE19558 [52]
for comparative genomics hybridizations.
GC content analysis of GIs
To calculate %GC content of each GI, a Python computer
script was written following a method of Madigan et al. [53] by
using complete nucleotide sequences of B. pseudomallei K96243
chromosomes 1 and 2 (downloaded from NCBI, GenBank:
NC_006350.1 and NC_006351.1) as the input data.
PCR verification of microarray data
The presence or absence of GIs3, 4, 6, 10, 13 and 16c in 5
tested isolates from the microarray hybridization was confirmed
using primers flanking a gene outside (positive control) and a gene
inside each GI by using TaqDNA polymerase (Roche Applied
Science, Indianapolis, IN). Further confirmation of the presence of
some selected virulence genes; FliC, bsaQ, rpoS, BPSL2800,
BPSS0120, BPSL1705 and BPSS2053 was also performed.
Primers for amplification of each GI and important genes were
listed in table S4. The presence of GIs8.1, 8.2, 13, 15 and 16c
were detected in 70 environmental and 64 clinical B. pseudomallei
isolates. The nucleotide sequences of primers to detect 5 GIs are
listed in Table 5.
Virulence of B. pseudomallei isolates in BALB/c mice
BALB/c mice (all male or female, 4 to 6 weeks of age) were
obtained from the National Laboratory Animal Center, Mahidol
University, Bangkok, Thailand. The maintenance and care of the
experimental animals complied with the National Animal Center
guidelines. The B. pseudomallei infected BALB/c mouse protocol
was approved by the animal ethics committee, Khon Kaen
University, Khon Kaen, Thailand (Reference No. 0514.1.12.2/
2). The most suitable numbers of bacteria were titrated to obtain
the killing efficiency that could be observed within 30 days;
almost all of the infected mice died. The experiment was
performed separately in duplicate to confirm the reliability of the
results. Therefore, groups of eight BALB/c mice, one group at
a time, were injected intraperitoneally with 100 ml of PBS
containing a suitable number of selected bacteria used in the
microarray experiment. The control group was injected with
PBS. The survival of the mice was recorded for 30 days post-
infection.
Statistical analysis
The differences in detection for the presence of GIs8.1, 8.2,
13, 15 and 16c by PCR between the clinical and environmental
groups were tested using chi-square. Survival times of mice
infected with various B. pseudomallei isolates were compared
using Kaplan-Meier curves and the log-rank test. Data were
considered statistically significant at P,0.05 (GraphPad Prism
5.0 software).
Supporting Information
Figure S1 Comparative genome analysis of B. pseudomallei
K96243 with B. pseudomallei BP28L environmental isolate (A),
clinical isolates P54 (B) and P82 (C). Low values of Log2
hybridization ratio imply absence of genes designated as GIs from
1–10 in chromosomes I and 11–15 in chromosome II. A slide
averaging window of 6 genes, one gene per step, was applied to the
normalized data and smoothed out the fluctuations of the data.
Each GI contains at least 6 CDS that have the value less than
22SD.
(DOC)
Figure S2 Data from microarray of all 15 absent GIs in
B. pseudomallei isolates. Low values of Log2 hybridization
ratios imply absence of genes visualized by Treeview software.
(DOC)
Table S1 The result of PCR detection of 4 GIs in 70 soil
isolates collected from 3 districts in Khon Kaen
province, northeast, Thailand.
(PDF)
Table S2 The result of PCR detection in 64 clinical
isolates obtained from melioidosis patients in 17
hospitals, northeast, Thailand.
(PDF)
Table S3 CDSs coordinates of genes in 15 GIs.
(DOC)
Table 5. Primer sequences used to detect 5 GIs in all B.
pseudomallei isolates (139 total).
Gene Primers
GI8.1 (BPSL1642) Forward AGTGCTAAGGCACCTGGAAA
Reverse GCGGGAAAGATCCTCCTTAT
GI8.2 (BPSL1708) Forward AACCCCTCACAACGAAAGG
Reverse GCCGCTGATTCCTGAGATAC
GI13 (BPSS0379) Forward CTACGCTTGCGCTTGTCTC
Reverse CCGAGCGAGTTTATCTCCAG
GI15 (BPSS1057) Forward CCAGTTGCTCGATGACCATA
Reverse CCGAGTTGGTGAACGTCAG
GI16c (BPSS2152) Forward CTCGTCTATGCGTACGATGC
Reverse CCAGCCGAACACCAGATAGT
doi:10.1371/journal.pone.0037762.t005
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and specific genes amplification.
(DOC)
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